Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
Aditi Sinha, Arvind Bagga, Sushmita Banerjee, et al.
Indian Pediatrics (2021) Vol. 58, Iss. 5, pp. 461-481
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome
Eugene Yu-hin Chan, Desmond Yat‐Hin Yap, Manuela Colucci, et al.
Clinical Journal of the American Society of Nephrology (2022) Vol. 18, Iss. 4, pp. 533-548
Open Access | Times Cited: 30
Consensus Guidelines on Management of Steroid-Resistant Nephrotic Syndrome
Anil Vasudevan, Ranjeet Thergaonkar, Mukta Mantan, et al.
Indian Pediatrics (2021) Vol. 58, Iss. 7, pp. 650-666
Closed Access | Times Cited: 32
Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects
Aditi Sinha, Georgie Mathew, Arushi Arushi, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 4, pp. 939-949
Closed Access | Times Cited: 21
An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome
Aditi Sinha, Kshetrimayum Ghanapriya Devi, Suprita Kalra, et al.
Kidney International (2024) Vol. 105, Iss. 5, pp. 1113-1123
Closed Access | Times Cited: 4
Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study
Sushmita Banerjee, Jayati Sengupta, Rajiv Sinha, et al.
Pediatric Nephrology (2024) Vol. 39, Iss. 10, pp. 2969-2977
Closed Access | Times Cited: 4
Optimal functioning of hypothalamic–pituitary–adrenal axis after cessation of prednisolone therapy: a cross-sectional study in children with nephrotic syndrome
M. Jaiganesh, Kirtisudha Mishra, Shikha Sharma, et al.
Pediatric Nephrology (2025)
Closed Access
Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome
Mara Sanches Guaragna, Fernanda Maria Casimiro da Fonseca, Patrícia Varela, et al.
Pediatric Nephrology (2025)
Closed Access
Determinants of Acute Kidney Injury in Children With Nephrotic Syndrome: A Prospective Observational Study
Nimisha Mohanty, Anil Kumar Goel, Manas Ranjan Sahoo, et al.
Cureus (2025)
Open Access
Short-term outcome of levamisole in frequently relapsing nephrotic syndrome: a single-center prospective cohort study
Sabeeta Khatri, Irshad Ali Bajeer, Aasia Zubair, et al.
Frontiers in Nephrology (2025) Vol. 5
Open Access
Consensus guidelines on management of steroid resistant nephrotic syndrome
Arvind Bagga, Anil Vasudevan, Ranjeet Thergaonkar, et al.
Asian Journal of Pediatric Nephrology (2021) Vol. 4, Iss. 2, pp. 67-67
Closed Access | Times Cited: 19
Clinical practice guidelines for nephrotic syndrome: consensus is emerging
Aditi Sinha, Arvind Bagga
Pediatric Nephrology (2022) Vol. 37, Iss. 12, pp. 2975-2984
Open Access | Times Cited: 13
Immunosuppressive Agent Options for Primary Nephrotic Syndrome: A Review of Network Meta-Analyses and Cost-Effectiveness Analysis
Kei Nagai
Medicina (2023) Vol. 59, Iss. 3, pp. 601-601
Open Access | Times Cited: 7
Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
Georgie Mathew, Aditi Sinha, Aijaz Ahmed, et al.
Pediatric Nephrology (2022) Vol. 37, Iss. 12, pp. 3117-3126
Open Access | Times Cited: 12
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Gurdeep Singh Dhooria, Siddharth Bhargava, Deepak Bhat, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Incidence and risk factors of acute kidney injury among childhood nephrotic syndrome: a prospective cohort study
Sanchari Ghosh, Shakil Akhtar, Subal Kumar Pradhan, et al.
European Journal of Pediatrics (2023) Vol. 182, Iss. 5, pp. 2443-2451
Closed Access | Times Cited: 6
Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review
Fiona Fung-yee Lai, Eugene Yu-hin Chan, Kjell Tullus, et al.
Pediatric Nephrology (2023) Vol. 39, Iss. 1, pp. 85-103
Closed Access | Times Cited: 5
Is kidney biopsy necessary in children with idiopathic nephrotic syndrome?
Zivile Békássy, Martin Lindström, Therese Rosenblad, et al.
Acta Paediatrica (2023) Vol. 112, Iss. 12, pp. 2611-2618
Open Access | Times Cited: 5
Current Understanding of Nephrotic Syndrome in Children
Tej K. Mattoo, Sami A. Sanjad
Pediatric Clinics of North America (2022) Vol. 69, Iss. 6, pp. 1079-1098
Closed Access | Times Cited: 8
Childhood Nephrotic Syndrome in Africa: Epidemiology, Treatment Trends, and Outcomes
Adebowale Ademola, Adanze Onyenonachi Asinobi, Michael Abel Alao, et al.
Seminars in Nephrology (2022) Vol. 42, Iss. 5, pp. 151311-151311
Closed Access | Times Cited: 8
Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review
Soumya R. Patil, Mahantesh Patil, Apoorva Bagalkotkar, et al.
Current Drug Safety (2024) Vol. 19, Iss. 4, pp. 489-496
Closed Access | Times Cited: 1
Adrenocortical suppression in children with nephrotic syndrome treated with corticosteroids
Ganesh M. Krishna, Aashima Dabas, Mukta Mantan, et al.
Pediatric Nephrology (2024) Vol. 39, Iss. 6, pp. 1817-1824
Closed Access | Times Cited: 1
Antineutrophil cytoplasmic antibody in children with nephrotic syndrome treated with levamisole: a cross-sectional cohort study
Rajiv Sinha, Subhankar Sarkar, Sushmita Banerjee, et al.
Pediatric Nephrology (2024) Vol. 39, Iss. 8, pp. 2423-2427
Closed Access | Times Cited: 1
Bioavailable Vitamin D Levels in Children With First Episode Nephrotic Syndrome: A Longitudinal Study
VD Charan, Abhijeet Saha, Rachita Singh Dhull, et al.
Indian Pediatrics (2024) Vol. 61, Iss. 10, pp. 941-946
Closed Access | Times Cited: 1
Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
Д.Д. Іванов, Lutz T. Weber, Elena Levtchenko, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2600-2600
Open Access | Times Cited: 1
Factors Predicting Short Term Outcome in Children With Idiopathic Nephrotic Syndrome: A Prospective Cohort Study
Irshad Ali Bajeer, Sabeeta Khatri, Seema Hashmi, et al.
Cureus (2022)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top